Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer

Noa Rabinowicz(Sheba Medical Center), Shai Izraeli(Tel Aviv University)

Oncotarget

March 10, 2017

10.18632/oncotarget.16068

Cited by 15

Related Papers

Childhood Acute Lymphoblastic Leukemia: Progress Through Collaboration

|Journal of Clinical Oncology|2015|1k

Diagnostic Assay Based on hsa-miR-205 Expression Distinguishes Squamous From Nonsquamous Non–Small-Cell Lung Carcinoma

|Journal of Clinical Oncology|2009|410

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

|Blood|2009|347

Gain-of-function mutations in <i>interleukin-7 receptor-α</i> ( <i>IL7R</i> ) in childhood acute lymphoblastic leukemias

|The Journal of Experimental Medicine|2011|346

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

|Cancer Cell|2016|304